Introduction

38
The mammalian immune system includes a multitude of weapons to defend against 39 invading microbes and successful pathogens have evolved a plethora of mechanisms to evade, 40 manipulate, or even benefit from these immune responses. One such pathogen, Salmonella 41 enterica serovar Typhimurium (hereafter referred to as Salmonella), has acquired a number of 42 Salmonella pathogenicity islands (SPI) that support its survival inside of a host organism. For 43 instance, Salmonella employs SPI-1 to invade non-phagocytic cells, and SPI-2 allows the bacteria 44 to survive intracellularly -including in macrophage -which is important for Salmonella 45 virulence (1-4). These traits allow Salmonella to invade the gut epithelium and induce intestinal 46 inflammation resulting in the characteristic gastroenteritis disease. Moreover, the induced 47 inflammation is not merely a threat that Salmonella must survive, but it has adapted to thrive in 48 the oxidative environment of the inflamed intestine and utilize inflammation-derived 49 metabolites to outcompete resident microbiota (5-7).
4
Itaconate is a metabolite originally recognized in fungal species such as Aspergillus 51 terreus and produced commercially for use in polymer industries (8, 9). A dicarboxylic acid 52 comprised of succinate with a methylene group, itaconate is able to act as an inhibitor of the 53 glyoxylate shunt enzyme AceA (isocitrate lyase) and can inhibit bacterial growth on carbon 54 sources that require this pathway, such as acetate (10-12). Interestingly, it has been 55 demonstrated that activated macrophage employ the IRG1 protein to produce itaconate, with 56 higher concentrations being produced by mouse macrophage than human (12-14). Moreover, 57 IRG1 closely associated with vesicles containing Legionella pneumophila and itaconate showed 58 bactericidal activity against this pathogen in vitro (14) . Itaconate was also found to inhibit 59 Salmonella growth by reducing media pH and itaconate levels correlated with splenomegaly in 60 Salmonella-infected mice (15). Cumulatively, these works suggest that itaconate acts as a 61 weaponized metabolite that the immune system employs to inhibit or kill invading bacteria. 62 If itaconate is an antibacterial metabolite functioning for the immune system then it 63 follows logically that successful pathogens must have methods to evade its effects. Indeed a 64 genetic operon in Yersinia (ripABC for 'required for intracellular proliferation') encodes proteins 5 survival in mice (20) (21) (22) hypothesized that the dicarboxylic acid chemistry of itaconate would allow it to act in a 93 bactericidal fashion at low pH by acting as a proton shuttle. In brief, the carboxyl groups of 6 itaconate (pK a = 5.5 and 3.8) protonate and lose their charge at lower pH allowing them to 95 traverse the bacterial membrane and release the protons in the more neutral pH of the 96 cytoplasm, thereby exacerbating acid stress ( Figure 1A ).
97
To emulate the intracellular conditions that Salmonella may encounter in a Salmonella 98 containing vacuole (SCV) of a macrophage we added itaconate to LPM media and then acidified 99 to pH 4.4, 5.0, or 5.8 to cover a range from the most acidic to more regular estimates of SCV pH 100 (24-26). Indeed we found that wild-type Salmonella showed a 1000-fold decrease in survival 101 after 3h hours at pH 4.4 with itaconate ( Figure 1B ). This lethality was alleviated at higher pH 102 and also occurred using a similar dicarboxylic acid, succinate. Importantly, the bactericidal 103 effect was also dependent on the presence of itaconate (or succinate) and pH 4.4 LPM did not 104 kill Salmonella in the absence of a dicarboxylic acid ( Figure S1A ). Interestingly, deletion of the 105 entire IRO (STM3120-STM3117) or aceA had no effect, but deletion of the general stress is the principal inducer ( Figure 3B ). Notably, similar results were obtained in complex media 131 (LB) and in MOPS minimal media with either glucose or glycerol as a carbon source, suggesting 132 that the induction only requires itaconate and not additional factors in the media ( Figure S2 ). 
143
In our hands, we found no significant reduction in survival of ΔIRO or ΔitaR strains in the mouse 144 J774 macrophage cell line ( Figure S4 ). When the macrophage were pre-stimulated with IFN-γ, 145 there was a slight reduction in survival relative to wild-type, but this was not significant when 146 compared to an aceA mutant that showed no survival defect. In contrast, a phoP mutant 147 control was readily inhibited by the macrophage even without IFN-γ. and GFP fluorescence (475nm and 511nm excitation and emission wavelengths respectively) 274 were read every 15 minutes. For clarity, bar graphs show fluorescence at 16h post inoculation.
275
Chloramphenicol was included in all media at a concentration of 20μg/ml to maintain the . Data are the average of at least three biological replicates and error bars show one standard deviation. pP itac , plasmidborne transcriptional fusion of P itac to sfGFP; pItaR-P itac , pP itac with the itaR gene and its native promoter included on the plasmid. A Games-Howell ANOVA was conducted comparing with and without itaconate for each strain (A), or comparing WT to ΔitaR (B) for each added metabolite. *, p < 0.05; **, p < 0.01; ***, p < 0.001. 
